Nuvation Bio NUVB Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years)
Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years) at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost.
The official record: Nuvation Bio’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvation Bio's available-for-sale debt securities - fair value (maturing 1 to 5 years).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvation Bio's available-for-sale debt securities - fair value (maturing 1 to 5 years)?
- Nuvation Bio (NUVB) reported available-for-sale debt securities - fair value (maturing 1 to 5 years) of $142.37M in Q4 2025.
- How has Nuvation Bio's available-for-sale debt securities - fair value (maturing 1 to 5 years) changed year-over-year?
- Nuvation Bio's available-for-sale debt securities - fair value (maturing 1 to 5 years) increased by 71.7% year-over-year, from $82.94M to $142.37M.
- What is the long-term trend for Nuvation Bio's available-for-sale debt securities - fair value (maturing 1 to 5 years)?
- Over 4 years (2021 to 2025), Nuvation Bio's available-for-sale debt securities - fair value (maturing 1 to 5 years) has grown at a -15.6% compound annual growth rate (CAGR), from $280.35M to $142.37M.
- What does available-for-sale debt securities - fair value (maturing 1 to 5 years) mean?
- This represents the fair value of debt securities held for investment purposes that are scheduled to mature within a one-to-five-year timeframe. It helps investors understand the company's medium-term liquidity profile and interest rate sensitivity.